0001415889-21-003398.txt : 20210702 0001415889-21-003398.hdr.sgml : 20210702 20210702161605 ACCESSION NUMBER: 0001415889-21-003398 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210702 DATE AS OF CHANGE: 20210702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUFFOLO ROBERT R CENTRAL INDEX KEY: 0001187308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39746 FILM NUMBER: 211070269 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc. CENTRAL INDEX KEY: 0001821323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474005543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-336-7540 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-07022021_040740.xml X0306 4 2021-07-01 0001821323 Sigilon Therapeutics, Inc. SGTX 0001187308 RUFFOLO ROBERT R C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 true false false false Common Stock 2021-07-01 4 M 0 6750 0.57 A 6750 D Common Stock 2021-07-01 4 S 0 6750 10.36 D 0 D Stock Option (Right to Buy) 0.57 2021-07-01 4 M 0 6750 0 D 2026-07-13 Common Stock 6750 48805 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.17 to $10.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The option vested as to 25% of the underlying shares of common stock on July 14, 2017, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested. /s/ Matthew Kowalsky, Attorney-in-Fact 2021-07-02